Biohaven Ltd.
BHVN
$15.61
$0.936.34%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 10.61% | -18.64% | -16.56% | 49.87% | -78.14% |
| Total Depreciation and Amortization | -11.93% | -8.74% | 23.42% | 2.05% | 35.13% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -83.51% | 198.51% | 664.31% | -102.01% | 248.03% |
| Change in Net Operating Assets | 525.15% | 27.43% | -129.32% | 188.02% | -190.99% |
| Cash from Operations | -1.70% | 3.29% | -20.86% | 15.81% | -63.49% |
| Capital Expenditure | 49.46% | -840.82% | 91.98% | 79.28% | -570.23% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 100.00% | -200.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -109.26% | 288.69% | 5.56% | 1.91% | -377.56% |
| Cash from Investing | -109.43% | 288.05% | 6.13% | 4.63% | -387.77% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 191.87% | -99.87% | 270.33% | -76.20% | 14,465.82% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -347.43% | 1,586.55% | -80.49% |
| Cash from Financing | 67,604.61% | -99.86% | 239.47% | -74.97% | 9,281.33% |
| Foreign Exchange rate Adjustments | -273.91% | -73.86% | -- | 100.00% | -16.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 45,007.48% | -98.99% | 109.41% | -378.58% | 184.96% |